Chemotherapy-induced Neutropenia Treatment Market 2030: The Shift...

added blog Other

2025-09-17 06:48:42 -

Chemotherapy-induced Neutropenia Treatment Market 2030: The Shift Towards Oral Treatments

The global chemotherapy-induced neutropenia (CIN) treatment market was valued at USD 1.63 billion in 2024 and is expected to decline to USD 1.51 billion by 2030, with a compound annual growth rate (CAGR) of -0.48% between 2025 and 2030. This projected decrease is largely influenced by regulatory challenges and pricing pressures in key markets, as governments and healthcare systems...

0 Comments 0 Shares 9 Views